Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 11.81 Delayed Data As of 1:35pm ET |  +0.06 / +0.51%Today’s Change | 9.83 Today|||52-Week Range 15.10 | -7.66% Year-to-Date |
| Previous close | 11.75 |
| Today’s open | 11.78 |
| Day’s range | 11.78 - 11.97 |
| Volume | 6,698 |
| Average volume (3 months) | 41,188 |
| Market cap | $153.8M |
| Dividend yield | -- |
| Earnings growth (last year) | +56.76% |
| Earnings growth (this year) | +93.33% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +21.27% |
| P/E ratio | NM |
| Price/Sales | 1.88 |
| Price/Book | 3.05 |
| Today’s change | Today’s % change | |
|---|---|---|
| IRIXIRIDEX Corp | -0.07 | -0.49% |
| FONRFonar Corp | +0.32 | +1.58% |
| DRADDigirad Corp | +0.04 | +0.79% |
| EARSAuris Medical Holdin... | 0.00 | 0.00% |
| Next reporting date | October 31, 2016 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $94.8M |
| Annual profit (last year) | -$4.4M |
| Net profit margin | -4.69% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive, Financial & Accounting Officer Ronald J. Santilli |
Vice President-Research & Development Michael Karavitis |
Corporate headquarters Brisbane, California |
